Early Trial Offers Hope Treating Rare 'Brittle Bone' Disease

MONDAY, Feb. 21, 2022 (HealthDay News) -- An experimental drug may help build bone mass in some adults with a rare brittle-bone disease, a small preliminary study suggests.

Related Keywords

New York ,United States ,Houston ,Texas ,Hospital For Special Surgery ,Baylor College Of Medicine ,Brendan Lee ,Cathleen Raggio ,Sanofi Genzyme ,Brittle Bone Disorders Consortium ,Us National Institutes Of Health ,Drug Administration ,Healthday News ,Baylor College ,Special Surgery ,Clinical Investigation ,Consumer News ,